Liquid assets: biopsies from the bloodstream

Dr Nicholas Turner, Consultant Medical Oncologist at the ICR and The Royal Marsden, discusses how assessing biomarkers circulating in the bloodstream could improve the way we treat cancer.

"This could transform how we treat cancer patients"

Dr Nicholas Turner

"It’s still early days, but circulating biomarkers have an exciting future in cancer treatment"